MedTrace Logo

Urine VOC Investigation in Bladder Cancer Diagnosis

NCT05671289 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2024-04-03

No results posted yet for this study

Summary

The goal of this study to investigate the volatile organic compounds (VOCs) in the urine samples of both healthy individual and bladder cancer patients, using gas chromatography - mass spectrometry. Researchers aim to find a set of certain VOCs specific to bladder cancer and use this set to construct a diagnostic model that can help diagnosing bladder cancer. Participants will be asked to collect their early morning midstream urine in a predesignated container. Researchers will compare urine VOCs from bladder cancer patients and healthy individuals to see if there is any VOC whose concentration differ significantly among the two groups.

Conditions

Interventions

DIAGNOSTIC_TEST

analysis of urine volatile organic compounds

gas chromatography - mass spectrometry will be used to assess the composition of VOCs in urine samples of all participants.

Sponsors & Collaborators

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Jinhai Fan, MD · First affiliated hospital of Xian jiaotong university

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-10
Primary Completion
2023-03-10
Completion
2023-03-10

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05671289 on ClinicalTrials.gov